116 results on '"Cars, Otto"'
Search Results
2. Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation
3. Equitable Access to Antibiotics: A Core Element and Shared Global Responsibility for Pandemic Preparedness and Response
4. Resetting the agenda for antibiotic resistance through a health systems perspective
5. Antibiotic Use in the Community
6. Global governance of antimicrobial resistance
7. Reply to Prim et al., “Is Colistin Susceptibility Testing Finally on the Right Track?”
8. Unavailability of old antibiotics threatens effective treatment for common bacterial infections
9. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
10. Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli
11. Colistin Is Extensively Lost during Standard In Vitro Experimental Conditions
12. Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance
13. Erratum to ‘Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia’
14. Assessment of early combination effects of colistin and meropenem againstPseudomonas aeruginosaandAcinetobacter baumanniiin dynamic time-kill experiments
15. Evaluation of automated time-lapse microscopy for assessment of in vitro activity of antibiotics
16. Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia
17. A Novel Microfluidic Assay for Rapid Phenotypic Antibiotic Susceptibility Testing of Bacteria Detected in Clinical Blood Cultures
18. Building bridges to operationalise one health – A Sino-Swedish collaboration to tackle antibiotic resistance
19. Antimicrobial resistance—a threat to the world’s sustainable development
20. UN High-Level Meeting on antimicrobials—what do we need?
21. Repeated nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals: data for actions 2003–2010
22. Dynamic interaction of colistin and meropenem on a WT and a resistant strain ofPseudomonas aeruginosaas quantified in a PK/PD model
23. Prevalence of hypermutators among clinicalAcinetobacter baumanniiisolates
24. Antibiotic resistance: An ethical challenge
25. A mechanism-based pharmacokinetic/pharmacodynamic model allows prediction of antibiotic killing from MIC values for WT and mutants
26. Changes in patterns of antibiotic use in Chinese public hospitals (2005–2012) and a benchmark comparison with Sweden in 2012
27. In Memoriam: William A. Craig
28. An international legal framework to address antimicrobial resistance
29. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
30. Universal Access to Effective Antibiotics is Essential for Tackling Antibiotic Resistance
31. Antibiotic use worldwide
32. Antibiotic Resistance — Problems, Progress, and Prospects
33. Mutant prevention concentrations of pradofloxacin for susceptible and mutant strains of Escherichia coli with reduced fluoroquinolone susceptibility
34. Securing access to effective antibiotics for current and future generations. Whose responsibility?
35. Access, excess, and ethics—towards a sustainable distribution model for antibiotics
36. Antibiotic resistance—the need for global solutions
37. Global survey of polymyxin use: A call for international guidelines
38. Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration
39. Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
40. Pharmacokinetic-Pharmacodynamic Model for Gentamicin and Its Adaptive Resistance with Predictions of Dosing Schedules in Newborn Infants
41. Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization
42. Protein Binding: Do We Ever Learn?
43. Posaconazole in Human Serum: a Greater Pharmacodynamic Effect than Predicted by the Non-Protein-Bound Serum Concentration
44. Critical shortage of new antibiotics in development against multidrug-resistant bacteria—Time to react is now
45. The global need for effective antibiotics—Moving towards concerted action
46. Predicting In Vitro Antibacterial Efficacy across Experimental Designs with a Semimechanistic Pharmacokinetic-Pharmacodynamic Model
47. Voriconazole-Induced Inhibition of the Fungicidal Activity of Amphotericin B in Candida Strains with Reduced Susceptibility to Voriconazole: an Effect Not Predicted by the MIC Value Alone
48. Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae
49. Fighting bacterial resistance at the root: need for adapted EMEA guidelines
50. The global need for effective antibiotics: challenges and recent advances
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.